Skip to main content
Premium Trial:

Request an Annual Quote

Health Discovery, IBM, Accelrys, NIH/NSF


Health Discovery Closes Fractal Genomics Acquisition

Health Discovery (formerly Direct Wireless) said on Jan. 2 that it has completed its acquisition of San Francisco-based bioinformatics company Fractal Genomics.

Under the terms of the acquisition agreement, Fractal Genomics founder Sandy Shaw will become vice president of fractal technology at Health Discovery.

Health Discovery said it plans to develop new research protocols for use with Fractal Genomics Modeling (FGM) software and begin validation studies on a set of leukemia genes discovered with the software.

IBM to Partner with FAST on Life Science Search Solutions

Fast Search & Transfer (FAST) of Oslo, Norway, has entered a partnership with IBM that covers the development, marketing, and sale of search technology for the life science market in Europe and North America.

Under the terms of the partnership agreement, the companies will integrate FAST Data Search, FAST’s enterprise search platform solution, with a range of IBM life science IT solutions.

Further terms of the agreement were not provided.

Accelrys to Distribute Jubilant BioSys’ Database

Accelrys said on Dec. 22 that it had agreed to become the exclusive distributor of Jubilant Biosys’ Kinase ChemBioBase, a kinase inhibitor database in the Catalyst 3D file format.

Accelrys will make the entire database available as a module in its Catalyst 4.9 rational drug design product suite. The database has over 160,000 compounds, covering about 320 unique kinase targets, including biological activity information for more than 60,000 compounds.

Accelrys said it anticipates incremental updates to the database of approximately 25,000 compounds per year.

NIH/NSF Support Second Year of Bioinformatics Summer School

Following on the success of last year’s program {BioInform 10-28-02], the NSF and the NIH’s National Institute of Biomedical Imaging and Bioengineering have announced a second year of support for the Bioengineering and Bioinformatics Summer Institutes (BBSI) Program.

The goal of the program, which is open to undergraduate students in their junior and senior year and to students entering their first and second year of graduate study, is to expose students to current research topics in computational biology and bioinformatics and encourage them to consider careers in bioengineering, bioinformatics, and computational biology.

BBSIs have been established at nine universities: the Southern California Bioinformatics Summer Institute at California State University at Los Angeles; the NIH-NSF Bioengineering and Bioinformatics Summer Institute in Biomaterials Science and Engineering at Clemson University; the NIH-NSF BBSI Summer Institute in Bioinformatics and Computational Biology at Iowa State University; the Biomedical Optics Summer Institute at Massachusetts Institute of Technology; the Bioinformatics Summer Institute at University of Minnesota; the BioMEMS Summer Bioengineering Institute at New Jersey Institute of Technology; the Biomaterials and Bionanotechnology Summer Institute at Penn State University; the Bioengineering and Bioinformatics Summer Institute in Computational Biology at the University of Pittsburgh; and the VCU Bioinformatics and Bioengineering Summer Institute at Virginia Commonwealth University.

Further information is available at

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.